Genetics of obesity and the prediction of risk for health.

Obesity has always existed in human populations, but until very recently was comparatively rare. The availability of abundant, energy-rich processed foods in the last few decades has, however, resulted in a sharp rise in the prevalence of obesity in westernized countries. Although it is the obesogenic environment that has resulted in this major healthcare problem, it is acting by revealing a sub-population with a pre-existing genetic predisposition to excess adiposity. There is substantial evidence for the heritability of obesity, and research in both rare and common forms of obesity has identified genes with significant roles in its aetiology. Application of this understanding to patient care has been slower. Until very recently, the health risks of obesity were thought to be well understood, with a straightforward correlation between increasing obesity and increasing risk of health problems such as type 2 diabetes, coronary heart disease, hypertension, arthritis and cancer. It is becoming clear, however, that the location of fat deposition, variation in the secretion of adipokines and other factors govern whether a particular obese person develops such complications. Prediction of the health risks of obesity for individual patients is not straightforward, but continuing advances in understanding of genetic factors influencing obesity risk and improved diagnostic technologies mean that the future for such prediction is looking increasingly bright.

[1]  C. Bouchard,et al.  Familial resemblance in fatness and fat distribution , 2000, American journal of human biology : the official journal of the Human Biology Council.

[2]  D. Abramovich,et al.  CIRCULATING LEPTIN IN WOMEN : A LONGITUDINAL STUDY IN THE MENSTRUAL CYCLE AND DURING PREGNANCY , 1998 .

[3]  J. Neel Diabetes mellitus: a "thrifty" genotype rendered detrimental by "progress"? , 1962, American journal of human genetics.

[4]  S. Grundy,et al.  The metabolic syndrome , 2003, The Lancet.

[5]  M. Nakazato,et al.  Ghrelin is a growth-hormone-releasing acylated peptide from stomach , 1999, Nature.

[6]  K. Clément,et al.  Hypoadiponectinaemia and high risk of type 2 diabetes are associated with adiponectin-encoding (ACDC) gene promoter variants in morbid obesity: evidence for a role of ACDC in diabesity , 2005, Diabetologia.

[7]  Shu-Chu Shiesh,et al.  Serum C-reactive protein as a marker for wellness assessment. , 2006, Annals of clinical and laboratory science.

[8]  John T McDevitt,et al.  Application of microchip assay system for the measurement of C-reactive protein in human saliva. , 2005, Lab on a chip.

[9]  Shyi-Jang Shin,et al.  Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. , 2006, The Journal of clinical endocrinology and metabolism.

[10]  P. J. Larsen,et al.  ACDC/Adiponectin and PPAR‐γ Gene Polymorphisms: Implications for Features of Obesity , 2005 .

[11]  J. Lemos,et al.  Current status of risk stratification methods in acute coronary syndromes , 2006, Current cardiology reports.

[12]  K. Clément,et al.  Variants of ENPP1 are associated with childhood and adult obesity and increase the risk of glucose intolerance and type 2 diabetes , 2005, Nature Genetics.

[13]  J. Puder,et al.  Menstrual cycle symptoms are associated with changes in low‐grade inflammation , 2006, European journal of clinical investigation.

[14]  B. Balkau,et al.  Bardet-Biedl Syndrome Gene Variants Are Associated With Both Childhood and Adult Common Obesity in , 2006 .

[15]  C. Amos,et al.  Possible genomic imprinting of three human obesity-related genetic loci. , 2005, American journal of human genetics.

[16]  P. Gounon,et al.  RNA-mediated non-mendelian inheritance of an epigenetic change in the mouse , 2006, Nature.

[17]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1995, Nature.

[18]  Patrick R. Griffin,et al.  A Receptor in Pituitary and Hypothalamus That Functions in Growth Hormone Release , 1996, Science.

[19]  N. Tritos,et al.  The physiology and potential clinical applications of ghrelin, a novel peptide hormone. , 2006, Mayo Clinic proceedings.

[20]  K. Flegal,et al.  Prevalence of overweight and obesity in the United States, 1999-2004. , 2006, JAMA.

[21]  L. Perrone,et al.  Molecular screening of the ghrelin gene in Italian obese children: the Leu72Met variant is associated with an earlier onset of obesity , 2004, International Journal of Obesity.

[22]  G. Paolisso,et al.  Role of interaction between variants in the PPARG and interleukin-6 genes on obesity related metabolic risk factors , 2005, Experimental Gerontology.

[23]  M. Fasshauer,et al.  Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. , 2005, Diabetes.

[24]  P. Boutin,et al.  Is glutamate decarboxylase 2 (GAD2) a genetic link between low birth weight and subsequent development of obesity in children? , 2005, The Journal of clinical endocrinology and metabolism.

[25]  S. O’Rahilly,et al.  A frameshift mutation in MC4R associated with dominantly inherited human obesity , 1998, Nature Genetics.

[26]  M. Lazar The humoral side of insulin resistance , 2006, Nature Medicine.

[27]  N. Fisher,et al.  Genetics of human hypertension , 2005, Trends in Endocrinology & Metabolism.

[28]  E. Bonora,et al.  Metabolic syndrome and cardiovascular disease , 2007, Annals of clinical biochemistry.

[29]  C. Wolberger,et al.  Structure of Nampt/PBEF/visfatin, a mammalian NAD+ biosynthetic enzyme , 2006, Nature Structural &Molecular Biology.

[30]  J. Pritchard,et al.  A Map of Recent Positive Selection in the Human Genome , 2006, PLoS biology.

[31]  S. Hankinson,et al.  Use of biomarkers in epidemiologic studies: minimizing the influence of measurement error in the study design and analysis , 2006, Cancer Causes & Control.

[32]  S. O’Rahilly,et al.  Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene , 1997, Nature Genetics.

[33]  P. Hwang,et al.  Preproghrelin Leu72Met Polymorphism in Obese Korean Children , 2005, Journal of pediatric endocrinology & metabolism : JPEM.

[34]  C. Maffeis,et al.  Long-Term Effects of Childhood Obesity on Morbidity and Mortality , 2001, Hormone Research in Paediatrics.

[35]  P. Froguel,et al.  A variation in the ghrelin gene increases weight and decreases insulin secretion in tall, obese children. , 2002, The Journal of clinical endocrinology and metabolism.

[36]  A. Fagot-Campagna Emergence of Type 2 Diabetes Mellitus in Children: Epidemiological Evidence , 2000, Journal of pediatric endocrinology & metabolism : JPEM.

[37]  B. Caballero A nutrition paradox--underweight and obesity in developing countries. , 2005, The New England journal of medicine.

[38]  C. Ebbeling,et al.  Childhood obesity: public-health crisis, common sense cure , 2002, The Lancet.

[39]  R. Sturm,et al.  The effects of obesity, smoking, and drinking on medical problems and costs. , 2002, Health affairs.

[40]  B. Wolfe,et al.  Weighing in on bariatric surgery: procedure use, readmission rates, and mortality. , 2005, JAMA.

[41]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1994, Nature.

[42]  M. Matsuda,et al.  Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. , 2005, Science.

[43]  A. Wolf,et al.  The medical‐care cost burden of obesity , 2001, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[44]  M. Olivier,et al.  Genetic linkage and association of the growth hormone secretagogue receptor (ghrelin receptor) gene in human obesity. , 2005, Diabetes.

[45]  T. Hansen,et al.  Mutation analysis of the preproghrelin gene: no association with obesity and type 2 diabetes. , 2005, Clinical biochemistry.

[46]  S. O’Rahilly,et al.  Monogenic obesity in humans. , 2005, Annual review of medicine.

[47]  P. J. Larsen,et al.  ACDC/adiponectin and PPAR-gamma gene polymorphisms: implications for features of obesity. , 2005, Obesity research.

[48]  Béatrice Jouret,et al.  ACDC/adiponectin polymorphisms are associated with severe childhood and adult obesity. , 2006, Diabetes.

[49]  B. Horsthemke,et al.  Imprinting defects on human chromosome 15 , 2006, Cytogenetic and Genome Research.

[50]  P. Budde,et al.  Peptidomics biomarker discovery in mouse models of obesity and type 2 diabetes. , 2005, Combinatorial chemistry & high throughput screening.

[51]  S. Santangelo,et al.  What is known about autism: genes, brain, and behavior. , 2005, American journal of pharmacogenomics : genomics-related research in drug development and clinical practice.

[52]  E. Ravussin,et al.  Role of ghrelin polymorphisms in obesity based on three different studies. , 2002, Obesity research.

[53]  K. Clément,et al.  GAD2 on Chromosome 10p12 Is a Candidate Gene for Human Obesity , 2003, PLoS biology.

[54]  M. Stumvoll,et al.  Genetic variation in the visfatin gene (PBEF1) and its relation to glucose metabolism and fat-depot-specific messenger ribonucleic acid expression in humans. , 2006, The Journal of clinical endocrinology and metabolism.

[55]  R. Norman,et al.  Variations in peripheral blood levels of immunoreactive tumor necrosis factor α (TNFα) throughout the menstrual cycle and secretion of TNFα from the human corpus luteum , 1999 .

[56]  P. Ernsberger,et al.  The epidemiology of overweight and obesity: public health crisis or moral panic? , 2006, International journal of epidemiology.

[57]  A. Grüters,et al.  Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans , 1998, Nature Genetics.

[58]  Susan L. Santangelo,et al.  What is Known About Autism , 2005 .

[59]  W. Chow,et al.  Relation of body mass index to cancer risk in 362,552 Swedish men , 2006, Cancer Causes & Control.

[60]  R. Norman,et al.  Variations in peripheral blood levels of immunoreactive tumor necrosis factor alpha (TNFalpha) throughout the menstrual cycle and secretion of TNFalpha from the human corpus luteum. , 1999, European journal of obstetrics, gynecology, and reproductive biology.

[61]  P. Hamet,et al.  Genetics and genomics of depression. , 2005, Metabolism: clinical and experimental.

[62]  I. Thompson,et al.  Obesity, Adipokines, and Prostate Cancer in a Prospective Population-Based Study , 2006, Cancer Epidemiology Biomarkers & Prevention.

[63]  Jian V. Zhang,et al.  Obestatin, a Peptide Encoded by the Ghrelin Gene, Opposes Ghrelin's Effects on Food Intake , 2005, Science.

[64]  M. King,et al.  Evidence of genetic influence on central body fat in middle-aged twins. , 1989, Human biology.

[65]  Paul M Ridker,et al.  C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients. , 2006, Journal of the American College of Cardiology.

[66]  E. Snyder,et al.  RAPID COMMUNICATIONS: Mutations in the Preproghrelin/Ghrelin Gene Associated with Obesity in Humans , 2001 .

[67]  M. Tabrizian,et al.  Enzymatically-generated fluorescent detection in micro-channels with internal magnetic mixing for the development of parallel microfluidic ELISA. , 2006, Lab on a chip.

[68]  A. Palou,et al.  Association of sets of alleles of genes encoding β3–adrenoreceptor, uncoupling protein 1 and lipoprotein lipase with increased risk of metabolic complications in obesity , 2000, International Journal of Obesity.

[69]  R. Lauer,et al.  The genetic and environmental sources of body mass index variability: the Muscatine Ponderosity Family Study. , 1991, American journal of human genetics.

[70]  M. McCarthy,et al.  Significant Linkage of BMI to Chromosome 10p in the U.K. Population and Evaluation of GAD2 as a Positional Candidate , 2006, Diabetes.

[71]  P. Froguel,et al.  The genetics of adiponectin , 2003, Current diabetes reports.

[72]  S. O’Rahilly,et al.  Congenital leptin deficiency is associated with severe early-onset obesity in humans , 1997, Nature.

[73]  B. Balkau,et al.  Bardet-Biedl Syndrome Gene Variants Are Associated With Both Childhood and Adult Common Obesity in French Caucasians , 2006, Diabetes.

[74]  Martin Kussmann,et al.  OMICS-driven biomarker discovery in nutrition and health. , 2006, Journal of biotechnology.

[75]  Kaare Christensen,et al.  Total and regional fat distribution is strongly influenced by genetic factors in young and elderly twins. , 2005, Obesity research.

[76]  C. Dinarello,et al.  Increased plasma interleukin-1 activity in women after ovulation. , 1985, Science.

[77]  K. Clément,et al.  A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction , 1998, Nature.

[78]  M. Quon,et al.  Inflammatory markers and the metabolic syndrome: insights from therapeutic interventions. , 2005, Journal of the American College of Cardiology.

[79]  A. Rissanen,et al.  Body weight in the Finnish Twin Cohort. , 1990, Diabetes research and clinical practice.

[80]  J. Pantel,et al.  Loss of constitutive activity of the growth hormone secretagogue receptor in familial short stature. , 2006, The Journal of clinical investigation.

[81]  I McNiece,et al.  Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor , 1994, Molecular and cellular biology.

[82]  M. Khoury,et al.  Does Genetic Testing Really Improve the Prediction of Future Type 2 Diabetes? , 2006, PLoS medicine.

[83]  R. Vettor,et al.  Reduced plasma visfatin/pre-B cell colony-enhancing factor in obesity is not related to insulin resistance in humans. , 2006, The Journal of clinical endocrinology and metabolism.

[84]  P. Kwok,et al.  Lack of Support for the Association between GAD2 Polymorphisms and Severe Human Obesity , 2005, PLoS biology.

[85]  J. Diamond,et al.  The double puzzle of diabetes , 2003, Nature.

[86]  K. Clément,et al.  A frameshift mutation in human MC4R is associated with a dominant form of obesity , 1998, Nature Genetics.

[87]  Claude Bouchard,et al.  The Human Obesity Gene Map: The 2005 Update , 2006, Obesity.

[88]  A. Rissanen,et al.  Intention to Lose Weight, Weight Changes, and 18-y Mortality in Overweight Individuals without Co-Morbidities , 2005, PLoS medicine.

[89]  H. Stefánsson,et al.  Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes , 2006, Nature Genetics.

[90]  P. Sullivan,et al.  Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. , 2003, Archives of general psychiatry.